Terms: = Gastric cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
23 results:
1. [Clinicopathological factors and clinical significance of No.12b lymph node metastasis in gastric antrum cancer].
Zhang B; Zheng GL; Zhang Y; Zhao Y; Zhu HT; Zhang T; Liu Y; Zheng ZC
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):167-174. PubMed ID: 38413085
[No Abstract] [Full Text] [Related]
2. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG; Lyu SI; Laible M; Wöll S; Türeci Ö; Şahin U; Alakus H; Fahrig L; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Transl Med; 2023 Aug; 21(1):552. PubMed ID: 37592303
[TBL] [Abstract] [Full Text] [Related]
3. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
Gebauer F; Plum PS; Damanakis A; Chon SH; Popp F; Zander T; Quaas A; Fuchs H; Schmidt T; Schröder W; Bruns CJ
Ann Surg Oncol; 2023 Nov; 30(12):7422-7433. PubMed ID: 37210683
[TBL] [Abstract] [Full Text] [Related]
4. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction.
Huang Q; Cheng Y; Lew E; Shi J; Wiener D; Weber HC
J Dig Dis; 2023 Feb; 24(2):98-112. PubMed ID: 36970757
[TBL] [Abstract] [Full Text] [Related]
5. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract] [Full Text] [Related]
6. Pepsinogen/Proton Pump Co-Expression in Barrett's Esophageal Cells Induces cancer-Associated Changes.
Stabenau KA; Samuels TL; Lam TK; Mathison AJ; Wells C; Altman KW; Battle MA; Johnston N
Laryngoscope; 2023 Jan; 133(1):59-69. PubMed ID: 35315085
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic impact of circulating miRNAs in patients with advanced esophagogastric cancer during palliative chemotherapy.
van Zweeden AA; Opperman RCM; Honeywell RJ; Peters GJ; Verheul HMW; van der Vliet HJ; Poel D
Cancer Treat Res Commun; 2021; 27():100371. PubMed ID: 33866108
[TBL] [Abstract] [Full Text] [Related]
8. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido F; Jimenez-Fonseca P; Carmona-Bayonas A; Arrazubi V; Hernandez R; Cano JM; Custodio A; Pericay Pijaume C; Aguado G; Martínez Lago N; Sánchez Cánovas M; Cacho Lavin D; Visa L; Martinez-Torron A; Arias-Martinez A; López F; Limón ML; Vidal Tocino R; Fernández Montes A; Alsina M; Pimentel P; Reguera P; Martín Carnicero A; Ramchandani A; Granja M; Azkarate A; Martín Richard M; Serra O; Hernández Pérez C; Hurtado A; Gil-Negrete A; Sauri T; Morales Del Burgo P; Gallego J
Gastric Cancer; 2021 Jul; 24(4):926-936. PubMed ID: 33651195
[TBL] [Abstract] [Full Text] [Related]
9. Unraveling the identity of gastric cardiac cancer.
Huang Q; Read M; Gold JS; Zou XP
J Dig Dis; 2020 Dec; 21(12):674-686. PubMed ID: 32975049
[TBL] [Abstract] [Full Text] [Related]
10. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract] [Full Text] [Related]
11. [Barrett-Screening: Rational, current concepts and perspectives].
Weismüller J; Thieme R; Hoffmeister A; Weismüller T; Gockel I
Laryngorhinootologie; 2020 Apr; 99(4):214-223. PubMed ID: 32314335
[TBL] [Abstract] [Full Text] [Related]
12. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
[TBL] [Abstract] [Full Text] [Related]
13. [Barrett-Screening: Rational, current concepts and perspectives].
Weismüller J; Thieme R; Hoffmeister A; Weismüller T; Gockel I
Z Gastroenterol; 2019 Mar; 57(3):317-326. PubMed ID: 30861556
[TBL] [Abstract] [Full Text] [Related]
14. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract] [Full Text] [Related]
15. Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.
Nortunen M; Huhta H; Helminen O; Parkkila S; Kauppila JH; Karttunen TJ; Saarnio J
Virchows Arch; 2018 Nov; 473(5):567-575. PubMed ID: 30066203
[TBL] [Abstract] [Full Text] [Related]
16. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract] [Full Text] [Related]
17. The management of localized esophageal squamous cell carcinoma: Western approach.
Zaidi N; Kelly RJ
Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
[TBL] [Abstract] [Full Text] [Related]
18. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract] [Full Text] [Related]
19. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract] [Full Text] [Related]
20. A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.
Xie SH; Lagergren J
Int J Cancer; 2016 Jun; 138(12):2813-9. PubMed ID: 26756848
[TBL] [Abstract] [Full Text] [Related]
[Next]
